{
    "clinical_study": {
        "@rank": "110779", 
        "acronym": "SIRUP", 
        "arm_group": [
            {
                "arm_group_label": "Stretta procedure", 
                "arm_group_type": "Experimental", 
                "description": "Patient randomized in Stretta procedure arm will be hospitalized to have endoscopy and esophagus will receive radiofrequency.\nControl visits will then take place until Month 6. At this visit endoscopic control will take place."
            }, 
            {
                "arm_group_label": "Sham procedure", 
                "arm_group_type": "Sham Comparator", 
                "description": "Patient randomized in Sham procedure arm will be hospitalized to have endoscopy. Material necessary to perform Stretta procedure  will be inserted (like in  Stretta procedure arm) BUT esophagus will not receive radiofrequency.\nControl visits will then take place until Month 6. At this visit endoscopic control will take place."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to compare the Stretta procedure and the Sham procedure efficiency\n      6months post-procedure in reflux uncontrolled by intake of Inhibitors of Protons Pump (IPP)\n      patients."
        }, 
        "brief_title": "Stretta In Reflux Uncontrolled by IPP", 
        "completion_date": {
            "#text": "March 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Gastroesophageal Reflux Disease", 
        "condition_browse": {
            "mesh_term": "Gastroesophageal Reflux"
        }, 
        "detailed_description": {
            "textblock": "The study is over a period of 1 year. After checking eligibility, the patient will be\n      randomised in double blind : stretta procedure /sham procedure. Control visits will take\n      place after 4 weeks (on site), 8 weeks (by phone), 12 weeks (by phone), 18 weeks(on site)\n      and 24 weeks(on site).During the 24 weeks visit, the therapeutic success will be evaluated.\n\n      In case of success, endoscopic control will be performed and the patient will come back on\n      site at week 36 and 48 (end of study). In case of therapeutic failure, the stretta procedure\n      will be proposed to the patient without breaking the blind for the 1st procedure.  The\n      procedure will be scheduled between week 24 and week 27. The patient will come back for a\n      visit on site at weeks 31, 36 and 48 (end of visit)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \u2265 18 ans\n\n          -  Severe or moderate heartburn (at least 3 heartburn times per week), persistent under\n             treatment with IPP\n\n        Exclusion Criteria:\n\n          -  Recent oeso-gastro-duodenal endoscopy(< 3 months)\n\n          -  Oesophagitis > grade A\n\n          -  Endobrachyoesophagus > C0M1\n\n          -  Hiatal Hernia  > 2 cm\n\n          -  Symptoms insufficiently relieved with continued intake of IPP or with intake of IPP\n             according to needs\n\n          -  Predominant symptom of Gastrooesophageal reflux disease other than heartburn\n\n          -  Patients contra-indicated for radiofrequency technique\n\n          -  Pregnant women"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01682265", 
            "org_study_id": "BRD 11/6-Q"
        }, 
        "intervention": [
            {
                "arm_group_label": "Stretta procedure", 
                "intervention_name": "Stretta procedure", 
                "intervention_type": "Other", 
                "other_name": "Radiofrequency of esophagus"
            }, 
            {
                "arm_group_label": "Sham procedure", 
                "description": "No radiofrequency delivered", 
                "intervention_name": "Sham procedure", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 11, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Stanislas Bruley des Varannes, Professor"
                }, 
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "state": "Loire Atlantique", 
                        "zip": "44093"
                    }, 
                    "name": "Nantes Universitary Hospital"
                }, 
                "investigator": {
                    "last_name": "Stanislas Bruley des Varannes, Professor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "frank.zerbib@chu-bordeaux.fr", 
                    "last_name": "Franck Zerbib, Professor", 
                    "phone": "+33 5 56 79 58 06"
                }, 
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France"
                    }, 
                    "name": "Bordeaux Universitary Hospital"
                }, 
                "investigator": {
                    "last_name": "Franck Zerbib, Professor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "thierry.ponchon@chu-lyon.fr", 
                    "last_name": "Thierry Ponchon, Professor", 
                    "phone": "+33 472110149"
                }, 
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69000"
                    }, 
                    "name": "Lyon Universitary Hospital"
                }, 
                "investigator": {
                    "last_name": "Thierry Ponchon, Professor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "philippe.ducrotte@chu-rouen.fr", 
                    "last_name": "Philippe Ducrotte, Professor", 
                    "phone": "+33 2 32 88 81 01"
                }, 
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France", 
                        "zip": "76000"
                    }, 
                    "name": "Rouen Universitary Hospital"
                }, 
                "investigator": {
                    "last_name": "Philippe Ducrotte, Professor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Stretta In Reflux Uncontrolled by Intake of Inhibitors of Protons Pump (IPP).- The SIRUP Trial- Multicentric, Randomized, Double Blind, Prospective Study", 
        "overall_contact": {
            "email": "stanilas.bruleydesvarannes@chu-nantes.fr", 
            "last_name": "Stanislas Bruley des Varannes, Professor", 
            "phone": "+33 2.40.08.33.06"
        }, 
        "overall_official": [
            {
                "affiliation": "Nantes Universitary Hospital", 
                "last_name": "Stanislas Bruley des Varannes, Professor", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Rouen Universitary Hospital", 
                "last_name": "Philippe Ducrotte, Professor", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Lyon Universitary Hospital", 
                "last_name": "Thierry Ponchon, Professor", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Bordeaux Universitary Hospital", 
                "last_name": "Franck Zerbib, Professor", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France-':ANSM'", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluate the efficiency of the treatment 6 months post-procedure according to the patient's answers to the 2 following items : IPP treatment taken less than 7 days /week and adequate relief of symptoms. These results will be completed by the patient on a calendar during 2 weeks before the visit week 24", 
            "measure": "Efficiency of the treatment 6 months post-procedure", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01682265"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Compare Stretta and sham procedure according to complete relief of digestive symptoms and pyrosis (calculation based upon number of days without digestive symptoms and pyrosis as indicated by the patient on a questionary completed during the 2 weeks preceding visits \u00e0 6 months)", 
                "measure": "Effects on digestive symptoms", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Compare Stretta and sham procedure according to complete relief of digestive symptoms and pyrosis (calculation based upon number of days without digestive symptoms and pyrosis as indicated by the patient on a questionary completed during the 2 weeks preceding visits \u00e0 12 months)", 
                "measure": "Effects on digestive symptoms", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Compare Stretta and sham procedure according to necessity of IPP treatment", 
                "measure": "Necessity of IPP treatment", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Compare Stretta and sham procedure according to necessity of IPP treatment", 
                "measure": "necessity of IPP treatment", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Compare Stretta and sham procedure according to Tolerance analysed by recording of adverse events (sides effects of each procedure) until week 24.", 
                "measure": "Tolerance", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Compare Stretta and sham procedure according to Tolerance analysed by recording of adverse events (sides effects of each procedure) until week 48.", 
                "measure": "Tolerance", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Compare Stretta and sham procedure according to Quality of life (use of quality of life questionaries)", 
                "measure": "Quality of live", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Compare Stretta and sham procedure according to Quality of life", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "pH-impedancemetry will be realized at clinical trial start, when patient is under PPI intake to determine pH-impedancemetry predictive factors for positive response to stretta method. Acid and non acid exposition of the esophagus will be measured as well as the SAP (Symptom Association Probability) which corresponds to the probability of association between symptoms felt by the patient during the pH-impedancemetry and episodes of acid or non acid reflux.", 
                "measure": "pH-impedancemetry predictive factors", 
                "safety_issue": "No", 
                "time_frame": "At Inclusion"
            }, 
            {
                "description": "Evaluate efficiency of the stretta procedure in patients unsatisfied after the sham procedure at week 48 according to the patient's answers to the 2 following items : IPP treatment taken less than 7 days /week and adequate relief of symptoms. These results will be completed by the patient on a calendar during 2 weeks before the visit week 48", 
                "measure": "Efficiency", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Evaluate efficiency of the  2nd stretta procedure  in patients unsatisfied after the 1st stretta procedure at week 48 according to the patient's answers to the 2 following items : IPP treatment taken less than 7 days /week and adequate relief of symptoms. These results will be completed by the patient on a calendar during 2 weeks before the visit week 48", 
                "measure": "Efficiency", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Nantes University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nantes University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}